Clinical Trial Update: L19IL2/L19TNF in Skin Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for L19IL2/L19TNF in skin cancer patients with various skin cancers; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous T-cell Lymphoma
• Kaposi Sarcoma
• Keratoacanthoma of the Skin
• Malignant Adnexal Tumors of the Skin
• Merkel Cell Carcinoma
• Squamous Cell Carcinoma

Drugs mentioned

• L19IL2/L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN